Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael R Ehrenstein

Showing results (31-40 of 68) with videos related to

Pageof 7
Sort By:
Arthritis and Rheumatism|October 18, 2002
An open study of B lymphocyte depletion in systemic lupus erythematosusMaria J Leandro, Jonathan C Edwards, Geraldine Cambridge, et al.
Rheumatology (Oxford, England)|May 4, 2021
The synergistic efficacy of hydroxychloroquine with methotrexate is accompanied by increased erythrocyte mean corpuscular volumeMuhammad Ruhul Amin Shipa, Su-Ann Yeoh, Andrew Embleton-Thirsk, et al.
Iscience|September 2, 2021
Regulatory T cells enhance Th17 migration in psoriatic arthritis which is reversed by anti-TNFDao X Nguyen, Helen M Baldwin, Amara N Ezeonyeji, et al.
Scientific Reports|February 8, 2017
DNA methylation governs the dynamic regulation of inflammation by apoptotic cells during efferocytosisClare A Notley, Christine K Jordan, Jenny L McGovern, et al.
Rheumatology (Oxford, England)|February 17, 2012
B-cell numbers and phenotype at clinical relapse following rituximab therapy differ in SLE patients according to anti-dsDNA antibody levelsMark N Lazarus, Tabitha Turner-Stokes, Konstantia-Maria Chavele, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 21, 2015
Engulfment of activated apoptotic cells abolishes TGF-β-mediated immunoregulation via the induction of IL-6Clare A Notley, Mark A Brown, Jenny L McGovern, et al.
BMC Medicine|February 14, 2023
Approaches to optimising access to NICE-approved biologic anti-TNFs for patients with rheumatoid arthritis with moderately active diseasePeter C Taylor, Ayman Askari, Ernest Choy, et al.
Arthritis and Rheumatism|October 23, 2010
Selective ERK activation differentiates mouse and human tolerogenic dendritic cells, expands antigen-specific regulatory T cells, and suppresses experimental inflammatory arthritisFrederick Arce, Karine Breckpot, Holly Stephenson, et al.
Rheumatology (Oxford, England)|March 15, 2011
The efficacy of repeated treatment with B-cell depletion therapy in systemic lupus erythematosus: an evaluationTabitha Turner-Stokes, Tim Y Lu, Michael R Ehrenstein, et al.
Arthritis and Rheumatism|June 8, 2012
Th17 cells are restrained by Treg cells via the inhibition of interleukin-6 in patients with rheumatoid arthritis responding to anti-tumor necrosis factor antibody therapyJenny L McGovern, Dao X Nguyen, Clare A Notley, et al.
Pageof 7

Showing results (31-40 of 68) with videos related to

Sort By:
Pageof 7
Arthritis and Rheumatism|October 18, 2002
An open study of B lymphocyte depletion in systemic lupus erythematosusMaria J Leandro, Jonathan C Edwards, Geraldine Cambridge, et al.
Rheumatology (Oxford, England)|May 4, 2021
The synergistic efficacy of hydroxychloroquine with methotrexate is accompanied by increased erythrocyte mean corpuscular volumeMuhammad Ruhul Amin Shipa, Su-Ann Yeoh, Andrew Embleton-Thirsk, et al.
Iscience|September 2, 2021
Regulatory T cells enhance Th17 migration in psoriatic arthritis which is reversed by anti-TNFDao X Nguyen, Helen M Baldwin, Amara N Ezeonyeji, et al.
Scientific Reports|February 8, 2017
DNA methylation governs the dynamic regulation of inflammation by apoptotic cells during efferocytosisClare A Notley, Christine K Jordan, Jenny L McGovern, et al.
Rheumatology (Oxford, England)|February 17, 2012
B-cell numbers and phenotype at clinical relapse following rituximab therapy differ in SLE patients according to anti-dsDNA antibody levelsMark N Lazarus, Tabitha Turner-Stokes, Konstantia-Maria Chavele, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 21, 2015
Engulfment of activated apoptotic cells abolishes TGF-β-mediated immunoregulation via the induction of IL-6Clare A Notley, Mark A Brown, Jenny L McGovern, et al.
BMC Medicine|February 14, 2023
Approaches to optimising access to NICE-approved biologic anti-TNFs for patients with rheumatoid arthritis with moderately active diseasePeter C Taylor, Ayman Askari, Ernest Choy, et al.
Arthritis and Rheumatism|October 23, 2010
Selective ERK activation differentiates mouse and human tolerogenic dendritic cells, expands antigen-specific regulatory T cells, and suppresses experimental inflammatory arthritisFrederick Arce, Karine Breckpot, Holly Stephenson, et al.
Rheumatology (Oxford, England)|March 15, 2011
The efficacy of repeated treatment with B-cell depletion therapy in systemic lupus erythematosus: an evaluationTabitha Turner-Stokes, Tim Y Lu, Michael R Ehrenstein, et al.
Arthritis and Rheumatism|June 8, 2012
Th17 cells are restrained by Treg cells via the inhibition of interleukin-6 in patients with rheumatoid arthritis responding to anti-tumor necrosis factor antibody therapyJenny L McGovern, Dao X Nguyen, Clare A Notley, et al.
Pageof 7